title: [Dental treatment and anti-thrombotic therapy. Part II: the era of new anti-thrombotic drugs].
abstract: Surgical intra-oral treatment for patients under antithrombotic therapy presents a challenge for the dental team. Within the last few years evidence based systematic reviews established new clinical guidelines for wide groups of patients which need to use antithrombotic treatment. The expected increase in use of antithrombotic treatment forced the pharmaceutical industry to provide new treatments. The former anticoagulant and anti-platelets aggregation groups of drugs were limited to small variety of medication. The search for the new treatments with ideal properties led to newly invented groups of drugs. In this article we will describe the new advancements in anti-thrombotic treatments. The article will summarize the limited knowledge of surgical management of patients under the new anti-thrombotic medications and the recommended approach for oral surgical procedures.
authors.forename: T
authors.initials: T
authors.lastname: Chackartchi
authors.forename: S
authors.initials: S
authors.lastname: Sachar Helft
authors.forename: M
authors.initials: M
authors.lastname: Findler
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage*; D015195:Drug Design; D005343:Fibrinolytic Agents / Q000008:administration & dosage; D006801:Humans; D019647:Oral Surgical Procedures / Q000379:methods*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage; D017410:Practice Guidelines as Topic
chemical_list: D000925:Anticoagulants; D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors